Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer UnitAi Otsuki, Yoh Watanabe, Hiroyuki Nomura, et al.
Vaccine|February 11, 2020
Emergent measles-containing vaccination recommendation for aged 6-11 months and detection of vaccine-associated measles during a large measles outbreak in Okinawa, Japan, in 2018Yumani Kuba, Hisako Kyan, Yoshiyuki Iha, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 20, 2005
[Isolation of Neisseria meningitidis from healthy persons in Japan]Hiroshi Tanaka, Toshiro Kuroki, Yuko Watanabe, et al.
Anticancer Research|July 31, 2012
Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trialReiki Nishimura, Yoshiaki Rai, Fumie Matsuo, et al.
BMC Cancer|December 1, 2020
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapyMunetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, et al.
Journal of Gynecologic Oncology|July 1, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trialShin Nishio, Tadaaki Nishikawa, Masahiko Mori, et al.
Gynecologic Oncology|November 9, 2017
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective studyMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.
Integrative Cancer Therapies|March 29, 2025
Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03)Yosuke Konno, Shunsuke Ohnishi, Shinichiro Minobe, et al.
Cancer Science|January 19, 2022
Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese womenMamiko Onuki, Kasumi Yamamoto, Hideaki Yahata, et al.
International Journal of Clinical Oncology|September 6, 2025
Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in JapanYoshikazu Nagase, Satoshi Nakagawa, Mariya Kobayashi, et al.
Pageof 11